Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy

By  

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 139-153

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling of Sulfonylmorpholinopyrimidines as the Ataxia Telangiectasis Mutated and RAD3-related (ATR) Protein Kinase Inhibitors by Computational Explorations

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 8, 2015-10 ,pp. : 661-672

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Research and Development of RAF Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1071-1089

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 16, Iss. 22, 2009-08 ,pp. : 2839-2854

Bentham Science Publishers

Access to resources Recommend Favorite